r 56865 has been researched along with Ventricular Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, HH; Lindert-Heimberg, S; Maisch, B; Nebendahl, K; Pich, S | 1 |
| Gwilt, M; Henderson, CG; Orme, J; Rourke, JD | 1 |
2 other study(ies) available for r 56865 and Ventricular Fibrillation
| Article | Year |
|---|---|
Effects of R56865, an Na(+)- and Ca(2+)-overload inhibitor, on myocardial injury in ischemic, reperfused porcine hearts.
Topics: Animals; Benzothiazoles; Blood Pressure; Calcium; Calcium Channel Blockers; Coronary Circulation; Female; Heart Rate; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Oxygen Consumption; Piperidines; Sodium; Sodium Channel Blockers; Swine; Thiazoles; Ventricular Fibrillation | 1995 |
Effects of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea-pig hearts in vitro.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Benzothiazoles; Calcium Channel Blockers; Disease Models, Animal; Glipizide; Glyburide; Guinea Pigs; In Vitro Techniques; Male; Myocardial Ischemia; Piperidines; Potassium; Potassium Channels; Pyrazines; Pyridines; Sympatholytics; Thiazoles; Ventricular Fibrillation | 1992 |